Table 1 Demographic and clinical characteristics of the group of 29 patients with resistant Social Anxiety Disorder (SAD) enrolled in the study.
From: Resistant social anxiety disorder response to Escitalopram
| Age | m: 34.6 sd: 9.9 (range 24–42) | |
| Gender | 13 M (44.8%)/16 F (55.2%) | |
| Education level (yrs) | m: 12.3 sd: 4.6 | |
| Marital status | Single n = 9 (31%) | |
| Married n = 16 (55.2%) | ||
| Divorced n = 4 (13.8%) | ||
| Duration of SAD (yrs) | m: 12.9 sd: 7.3 | |
| Baseline LSAS score | m: 62.4 sd: 10.6 | |
| Baseline HSRD score | m: 12.68 sd: 2.42 | |
| Baseline CGI-S | m: 4.8 sd: 1.1 | |
| CGI-I (Paroxetine trial) | m: 4.3 sd: 0.5 | |
| Baseline SDS Work | m: 7.6 sd: 1.8 | |
| Baseline SDS Social | m: 8.5 sd: 2.0 | |
| Baseline SDS Family | m: 5.2 sd: 1.3 | |
| Baseline ASEX | m: 19.4 sd: 2.3 | |
| Lifetime comorbidity | ||
| Axis I | Depressive disorder | 5 (17.2%) |
| Cyclothimia | 2 (6.9%) | |
| Panic disorder | 6 (20.7%) | |
| Somatoform disorder | 3 (10.3%) | |
| Obsessive-Compulsive Dis. | 2 (6.9%) | |
| Alcohol abuse | 5 (17.2%) | |
| Substance abuse | 2 (6.9%) | |
| Axis 2 | Avoidant PD | 4 (13.8%) |
| Obsessive-Compulsive PD | 1 (3.4%) | |
| Passive-Aggressive PD | 1 (3.4%) | |
| Narcissistic PD | 1 (3.4%) |